“Olaris has developed a powerful platform for discovering actionable metabolomic biomarkers,” said Dr. Falko Busse, the President of the Bruker BioSpin Group. “We are excited to support their vision and collaborate on driving new applications of metabolomics in precision health.” Post this “We are thrilled to have Bruker as a strategic investor and partner,” said … Read more
But how do these microbial communities work? And can we harness their power to make agriculture more sustainable? These questions have driven Professor Julia Vorholt’s groundbreaking research work, which has now earned her the 2025 Novonesis Biotechnology Prize, awarded by the Novo Nordisk Foundation. “Receiving this prize is a tremendous honour,” says Vorholt, who is … Read more
Successful completion of a phase I clinical study for improving local control in patients with advanced colorectal cancer undergoing surgery ROCKY HILL, Conn., Jan. 27, 2025 /PRNewswire-PRWeb/ — Lumeda Inc. (“Lumeda”), a biophotonics systems company formed to advance photodynamic therapy (PDT) for treating cancer, today announced the completion of a phase 1 clinical by Roswell … Read more